Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness
PLOS ONE · 08.11.2023 · 18 (11) · e0291382
DOI: 10.1371/journal.pone.0291382 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 08.11.2023. Verfasst von Victoria P Sanderson und 6 weiteren Autor:innen. Beteiligte Einrichtung: G. Magnotta Lyme Disease Research Lab, Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: Borrelia, Fibromyalgia, Lyme Disease, Borrelia burgdorferi. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: G. Magnotta Foundation for Vector-Borne Diseases, The McCain Foundation, Rotary Woodstock NB.
Abstract (Originalsprache)
Lyme disease, caused by vector-borne Borrelia bacteria, can present with diverse multi-system symptoms that resemble other conditions. The objective of this study was to evaluate disease presentations and Borrelia seroreactivity in individuals experiencing a spectrum of chronic and complex illnesses. We recruited 157 participants from Eastern Canada who reported one or more diagnoses of Lyme disease, neurological, rheumatic, autoimmune, inflammatory, gastrointestinal, or cardiovascular illnesses, or were asymptomatic and presumed healthy. Intake categories were used to classify participants based on their perceived proximity to Lyme disease, distinguishing between those with a disclosed history of Borrelia infection, those with lookalike conditions (e.g. fibromyalgia syndrome), and those with unrelated ailments (e.g. intestinal polyps). Participants completed three questionnaires, the SF-36 v1, SIQR, and HMQ, to capture symptoms and functional burden, and provided blood serum for analysis at an accredited diagnostic lab. Two-tiered IgG and IgM serological assessments (whole cell ELISA and Western blot) were performed in a blinded fashion on all samples. The pattern of symptoms and functional burden were similarly profound in the presumptive Lyme and Lyme-like disease categories. Borrelia seroprevalence across the study cohort was 10% for each of IgG and IgM, and occurred within and beyond the Lyme disease intake category. Western blot positivity in the absence of reactive ELISA was also substantial. Fibromyalgia was the most common individual diagnostic tag disclosed by two-tier IgG-positive participants who did not report a history of Lyme disease. Within the IgG seropositive cohort, the presence of antibodies against the 31 kDa Outer Surface Protein A (OspA) was associated with significantly better health outcomes. Previously, this marker has been linked to treatment-refractory Lyme arthritis. Overall, our findings support prior observations of phenotypic overlap between Lyme and other diseases. Seropositivity associated with non-specific symptoms and functional impairment warrants further mechanistic investigation and therapeutic optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- G. Magnotta Lyme Disease Research Lab, Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
- Galaxy Diagnostics, Research Triangle Park, North Carolina, Raleigh, United States of America.
- Department of Biology, Mount Allison University, Sackville, New Brunswick, Canada.
- Upper River Valley Hospital, Horizon Health Network, Waterville, New Brunswick, Canada.
ORCID-Profile: Vladimir V Bamm, Gurpreet Singh-Ranger, Melanie K B Wills
Förderung
- G. Magnotta Foundation for Vector-Borne Diseases
- The McCain Foundation
- Rotary Woodstock NB
Zitieren
APA
Sanderson, V. P., Miller, J. C., Bamm, V. V., Tilak, M., Lloyd, V. K., Singh-Ranger, G., & Wills, M. K. B. (2023). Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness. PLOS ONE, 18(11), e0291382. https://doi.org/10.1371/journal.pone.0291382
Vancouver
Sanderson VP, Miller JC, Bamm VV, Tilak M, Lloyd VK, Singh-Ranger G, et al. Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness. PLOS ONE. 2023;18(11):e0291382. doi:10.1371/journal.pone.0291382
BibTeX
@article{Sanderson2023,
author = {Sanderson, Victoria P and Miller, Jennifer C and Bamm, Vladimir V and Tilak, Manali and Lloyd, Vett K and Singh-Ranger, Gurpreet and Wills, Melanie K B},
title = {Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {11},
pages = {e0291382},
doi = {10.1371/journal.pone.0291382}
}
EUVIMED